You will partner across Government Affairs and Advocacy, Market Access, Legal, Commercial, Medical Affairs, Regulatory Policy, Communications, Finance, Manufacturing/Supply Chain, and US/global Therapeutic Area teams to translate complex policy issues into clear business implications and actionable strategies. Monitor, analyze, and forecast legislative and regulatory developments across the full US policy landscape affecting CSL, including drug pricing reform, Medicare and Medicaid policy, 340B, rebate and PBM reform, intellectual property and patent policy, trade policy, tax policy, and manufacturing and supply chain policy.